Differential Effect of β-Adrenergic Stimulation on the Frequency-Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293.
Corresponding Author
JÜRGEN SCHREIECK M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Jürgen Schreieck, M.D., I. Medizinische Klinik, Technische Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Germany, Fax: 49-89-1218-4593.Search for more papers by this authorYANGGAN WANG M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorVIKTOR GJINI M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorMICHAEL KORTH M.D.
Institut für Pharmakologie, Universität Hamburg, Hamburg, Germany
Search for more papers by this authorBERNHARD ZRENNER M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorALBERT SCHÖMIG M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorCLAUS SCHMITT M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorCorresponding Author
JÜRGEN SCHREIECK M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Jürgen Schreieck, M.D., I. Medizinische Klinik, Technische Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Germany, Fax: 49-89-1218-4593.Search for more papers by this authorYANGGAN WANG M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorVIKTOR GJINI M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorMICHAEL KORTH M.D.
Institut für Pharmakologie, Universität Hamburg, Hamburg, Germany
Search for more papers by this authorBERNHARD ZRENNER M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorALBERT SCHÖMIG M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorCLAUS SCHMITT M.D.
I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich
Search for more papers by this authorThis work was supported by a grant from the Lilly Foundation.
Presented in part at the 45th Annual Scientific Session of the American College of Cardiology. Orlando, Florida. March 27, 1996.
Abstract
Class III Antiarrhythmics and β-Adrenergic Stimulation. Introduction: Blockade of the rapid delayed rectifier potassium current (IKr) as an important mechanism for current Class III antiarrhythmics is less effective in action potential prolongation during β-adrenergic activation. We hypothesized that blockade of the increased slow IK (IKs) current during β-adrenergic stimulation could improve action potential prolongation and tested this hypothesis by comparison of three different IK blockers: dofetilide, a selective blocker of IKr; ambasilide, a nonselective blocker of IK; and chromanol 293B, a selective blocker of IKs.
Methods and Results: Transmembrane action potential duration was determined in guinea pig papillary muscles. After equilibration with the potassium channel blockers (dofetilide 10 nM, amhasilide 10 μM, chromanol 293B 10 μM), isoproterenol (10 and 100 nM) was added. The action potential prolonging effect of dofetilide was reduced in the presence of increasing concentrations of isoproterenol whereas the effect of ambasilide was much less reduced. In contrast, the effect of chromanol 293B clearly was increased in the presence of both concentrations of isoproterenol. No afterdepolarizations were observed after application of isoproterenol in control. Following isoproterenol, but not before, dofetilide and chromanol 293B induced early afterdepolarizations in 20% and 17% of the papillary muscles, whereas ambasilide and chromanol 293B induced delayed afterdepolarizations in 27% and 17%, respectively.
Conclusion: In contrast to dofetilide, the Class III effect of ambasilide is less reduced and the effect of chromanol 293B is enhanced during β-adrenergic stimulation. Our data support the hypothesis that IKs blockade improves the efficacy of antiarrhythmics in action potential prolongation during β-adrenergic activation; however, this effect may increase the risk of afterdepolarizations.
References
- 1 Yusuf S, Peto R, Lewis J, et al: Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335–371.
- 2 Freedman RA, Swerdlow CD, Echt DS, et al: Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol 1984; 54: 765–770.
- 3 Reddy CP, Gettes LS: Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol 1979; 44: 705–713.
- 4 Jazayeri MR, Van Wyhe G, Avitall B, et al: Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1989; 14: 705–711.
- 5 Morady F, Kou WH, Kadish AH, et al: Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia. Circulation 1989: 79: 783–790.
- 6 Vanoli E, Priori SG, Nakagawa H, et al: Sympathetic activation, ventricular repolarization and IKr blockade: Implications for antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol 1995; 25: 1609–1624.
- 7 Sanguinetti MC, Jurkiewicz NK, Scott A, et al: Isoproterenol antagonizes prolongation of refractory period by class III antiarrhythmic agents E-4031 in guinea pig myocytes: Mechanisms of action. Circ Res 1991; 68: 77–84.
- 8 Sager PT, Follmer C, Uppal P, et al: The effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Circulation 1994: 90: 1811–1819.
- 9 Groh WJ, Gibson KJ, McAnulty JH, et al: Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol. Circulation 1995; 91: 262–264.
- 10 Kato R, Ikeda N, Yabek SM, et al: Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol 1986: 7: 116–125.
- 11 Kadish AH, Chen R-F, Schmaltz S, et al: Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy, J Am Coll Cardiol 1990; 16: 1240–1245.
- 12 Du X-J, Esler MD, Dart AM: Sympathotytic action of intravenous amiodarone in the rat heart. Circulation 1995: 91: 462–470.
- 13 Sager P. T., Behboodikhah M: Frequency-dependent electrophysiologic effects of d, l-sotalol and quinidine and modulation by beta-adrenergic stimulation. J Cardiovasc Electrophysiol 1996; 7: 102–112.
- 14 Shenasa H, Shenasa M: Reversibility of antiarrhythmic effects of sotalol by isoproterenol in patients with ventricular tachycardia. In PP Vereecke, PP Bogaert, F Verdonck, eds; Potassium Channels in Normal and Pathological Conditions. Leuven University Press, Leuven . 1995, pp. 400–406.
- 15
Newman D,
Dorian P,
Feder-Elituv R: Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
Can J Physiol Pharmacol
1993; 7l: 755–760.
10.1139/y93-113 Google Scholar
- 16 Waldo AL, Camm AJ, DeRuyter H, et al: Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial). Am J Cardiol 1995; 75: 1023–1027.
- 17 Sager PT, Behboodikhah M, Ahmed R, et al: Frequency dependent effects of beta-adrenergic stimulation on ventricular repolarization, refractoriness, and conduction in humans, (Abstract), J Am Coll Cardiol 1994; 23: 371A.
- 18 Sanguinetti MC, Jurkiewicz NK: Two components of cardiac delayed rectifier K+ current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990; 96: 194–214.
- 19 Busch AE, Suessbrich H, Waldegger S, et al: Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by chromanol 293B. Pflügers Arch 1996; 432: 1094–1096.
- 20 Suessbrich H, Bleich M, Ecke D et al: Specific blockade of slowly activating IsK channels by chromanols: impact on the role of IsK channels in epithelia. FEBS Lett 1996: 396: 271–275.
- 21 Zhang ZH, Follmer CH, Sarma JSM, et al: Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: Block of delayed outward potassium current. J Pharmacol Exp Ther 1992: 263: 40–48.
- 22 Carmeliet E: Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992: 262: 809–817.
- 23 Zeng J, Laurita KR, Rosenbauni DS, et al: Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Circ Res 1995: 77: 140–152.
- 24 Veldkamp MW, van Ginneken ACG, Opthof T, et al: Delayed rectifier channels in human ventricular myocytes. Circulation 1995; 92: 3497–3504.
- 25 Beuckelmann DJ, Näbauer M, Erdmann E: Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993: 73: 379–385.
- 26 Li GR, Feng J, Yue L, et al: Evidence for two components of delayed rectifier K+ currents in human ventricular myocytes. Circ Res 1996: 78: 689–696.
- 27 Wang Z, Fermini B, Nattel S: Rapid and slow components of the delayed rectifier current in human atrial myocytes. Circ Res 1994; 28: 1540–1546.
- 28 Sager PT: Frequency-dependent electrophysiologic effect of dofetilide in humans (Abstract). Circulation. 1995; 92(Suppl): 1–774.
- 29 Montero M, Schmitt C: Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents d-sotalol and dofetilide. J Cardiovasc Pharmacol 1996; 27: 571–577.
- 30 Bosch RF, Gaspo R, Busch AE, et al: Effects on repolarization of the chromanol 293B, a highly selective blocker of the slow component of the delayed rectifier K+ current (IKs) in human and guinea pig ventricle (Abstract). J Am Coll Cardiol 1997: 29(Suppl A): 512A.
- 31
Schreieck J,
Korth M,
Weyerbrock S, et al: Rate-independent prolongation of transmembrane action potential by ambasilide in failing human myocardium (Abstract).
J Am Coll Cardiol
1996: 27(Suppl A): 374A.
10.1016/S0735-1097(96)82420-X Google Scholar
- 32 Schmitt C, Karch M, Schreieck J, et al: Effect of the new class III antiarrhythmic agent ambasilide on monophasic and transmembrane action potential in human ventricular myocardium (Abstract). PACE 1996; 19: 692.
- 33 Honerjäger P: The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs. Basic Res Cardiol 1986; 81: 33–37.
- 34 Hille B: Ionic Channels of Excitable Membranes. Sinauer Assoc, Inc., Sunderland MA , 1992.
- 35 Sakakibara Y, Furukawa T, Singer D, et al: Sodium current in isolated human ventricular myocytes. Am J Physiol 1993; 265: H1301–H1309.
- 36 Coraboeuf E, Deroubaix E, Coulombe A: Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am J Physiol 1995; 236: H561–H567.
- 37 Honerjäger P, Reiter M: Sarcolemmal sodium permeability and contractile force of guinea pig papillary muscle: Effects of germitrine. Circ Res 1977: 40: 90–98.
- 38 Cranefield PF, Aronson RS: Cardiac Arrhythmias: the Role of Triggered Activity and Other Mechanisms. Futura Publishing Co., Inc., Mount Kisco , NY , 1988.
- 39 Yazawa K, Kameyama M: Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea-pig ventricular myocytes. J Physiol 1990: 421: 135–150.
- 40 Korth M, Schmied R: Differential effects of (-)-norepinephrine and of (±)-isoproterenol on cardiac contraction, an uptake phenomenon. J Pharmacol Exp Ther 1988: 247: 1164–1171.
- 41 Koidel B, Flaschberger P, Schaffer P, et al: Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol 1996; 353: 226–232.
- 42 Matsuura H, Ehara T, Imoto Y: An analysis of the delayed outward current in single ventricular cells of the guinea-pig. Pflügers Arch 1987; 410: 596–603.
- 43 Zaza A, Malfatto G, Schwartz PJ: Effects on atrial repolarization of the interaction between K+ channels and muscarinic receptor stimulation. J Pharmacol Exp Ther 1995; 273: 1095–1104.
- 44 Carmeliet E, Mubagwa K: Changes by acetylcholine of membrane currents in rabbit cardiac Purkinje fibres. J Physiol (Lond) 1986; 371: 201–217.
- 45 Pappano AJ, Mubagwa K: Actions of muscarinic agents and adenosine on the heart. In HA Fozzard, ed: The Heart and the Cardiovascular System. Raven Press. New York , 1992, pp. 1763–1776.
- 46 Takanaka C, Sarma JSM, Singh BN: Electrophysiologic effects of ambasilide (LU 47110), a novel class in antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle. J Cardiovasc Pharmacol 1992; 19: 290–298.
- 47 Levesque PC, Clark CD, Zakarov SI, et al: Anion and cation modulation of the guinea-pig ventricular action potential during beta-adrenoceptor stimulation. Pflügers Arch 1993: 424: 54–62.
- 48 Wang J, Feng J, Nattel S: Class III antiarrhythmic drug action in experimental atrial fibrillation: Differences in reverse use dependence and effectiveness between dsotalol and the new antiarrhythmic drug ambasilide. Circulation 1994; 90: 2032–2040.
- 49 Salata JJ, Jurkiewicz NK, Sanguinetti MC, et al: The novel class III antiarrhythmic agent, L-735,821 is a potent and selective blocker of IKs in guinea pig ventricular myocytes (Abstract). Circulation 1996: 94(Suppl I): I–529.
- 50 Jurkiewicz N, Sanguinetti M: Rate-dependent prolongation of action potentials by a methanesulfonanilide class III antiarrhythmic agent: Specific block of rapidly activating K+ current by dofetilide. Circ Res 1993: 72: 75–83.
- 51 Hoffman BF, Dangman KH: Are arrhythmias caused by automatic impulse generation? In A Paes de Carvalho, BF Hoffman, M Lieberman, eds: Normal and Abnormal Conduction in the Heart. Futura Publishing Co., Inc., Mount Kisco , NY . 1982, pp. 429–448.
- 52 Damiano BP, Rosen MR: Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation 1984; 69: 1013–1025.
- 53 Liu D-W, Antzelevitch C: Characteristics of the delayed rectifier current (IKr and IKs in canine ventricular epicardial, midmyocardial, and endocardial myocytes: A weaker IKs contributes to the longer action potential of the M cell. Circ Res 1995: 76: 351–365.
- 54 Wettwer E, Amos GJ, Posival H, et al: Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res 1994; 75: 473–482.
- 55 Montero M, Schmitt C: Differential effects of d-sotalol on endocardial and epicardial action potentials of human ventricular myocardium in dilated cardiomyopathy. J Cardiovasc Pharmacol 1994: 24: 883–889.
- 56 Hondeghem LM, Snyders DJ: Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 1990; 81: 686–690.
- 57 Stramba-Badiale M, Pessano P, Kirchengast M, et al: Effects of the potassium channel blocking agent ambasilide on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation. Am Heart J 1995; 129: 549–556.
- 58 Vanoli E, Hull SS, Adamson PB, et al: K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. J Cardiovasc Pharmacol 1995; 26: 847–854.
- 59 Barhanin J, Lesage F, Guillemare E, et al: KVLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature 1996; 384: 78–80.
- 60 Sanguinetti MC, Curran ME, Zou A, et al: Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature 1996; 384: 80–83.